Cargando…
Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy
BACKGROUND: Tauopathies comprise a family of neurodegenerative disorders including Alzheimer’s disease for which there is an urgent and unmet need for disease-modifying treatments. Tauopathies are characterized by pathological tau hyperphosphorylation, which has been shown to correlate tightly with...
Autores principales: | Alavi Naini, Seyedeh Maryam, Yanicostas, Constantin, Hassan-Abdi, Rahma, Blondeel, Sébastien, Bennis, Mohamed, Weiss, Ryan J., Tor, Yitzhak, Esko, Jeffrey D., Soussi-Yanicostas, Nadia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855975/ https://www.ncbi.nlm.nih.gov/pubmed/29568517 http://dx.doi.org/10.1186/s40035-018-0111-2 |
Ejemplares similares
-
Correction to: Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy
por: Naini, Seyedeh Maryam Alavi, et al.
Publicado: (2020) -
Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?
por: Alavi Naini, Seyedeh Maryam, et al.
Publicado: (2015) -
Heparan Sulfate as a Therapeutic Target in Tauopathies: Insights From Zebrafish
por: Alavi Naini, Seyedeh Maryam, et al.
Publicado: (2018) -
Neurons Expressing Pathological Tau Protein Trigger Dramatic Changes in Microglial Morphology and Dynamics
por: Hassan-Abdi, Rahma, et al.
Publicado: (2019) -
Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis
por: Warford, Jordan R., et al.
Publicado: (2018)